Eurepa MF (Repaglinide/ Metformin) 1/500mg – 100 tablet

USD $75.52

Each Eurepa MF contains 1 mg Repaglinide 500 mg Metformin 100 tablets. Used to treat diabetic adults who suffer from Diabetes Mellitus type 2 diabetes.

ATC Classification: A10BD14
Active Ingrediant: Repaglinide/Metformin
Generic Name: Eurepa MF
Manufacturer: Torrent
Strength: 1/500mg
Dosage Type: Tablet
Packaging Type: Foil in Box
Contains: 100 TABLET

Examples of Packages sent

 

What is this drug used for?

It is used to lower blood sugar in patients with high blood sugar (diabetes).

 

Pronunciation

(re PAG li nide & met FOR min)

 

Medication Safety Issues

Sound-alike/look-alike issues:

PrandiMet may be confused with Avandamet, Prandin

 

Storage/Stability

Do not store above 25?C (77?F). Protect from moisture.

 

Adverse Reactions

The following information reflects the frequency of adverse effects experienced by patients who received the repaglinide/metformin fixed-dose combination product. Also see individual agents.

>10%:

Central nervous system: Headache (22%)

Endocrine & metabolic: Hypoglycemia (33%)

Gastrointestinal: Diarrhea (19%), nausea (15%)

Respiratory: Upper respiratory tract infection (11%)

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , ,

Strength

Dosage Type

Packaging Type

Brand

Torrent Pharma

Reviews

There are no reviews yet.

Be the first to review “Eurepa MF (Repaglinide/ Metformin) 1/500mg – 100 tablet”

Your email address will not be published. Required fields are marked *